Stay updated with breaking news from Nexcelom Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Flow Cytometry Market by Product (Analyzer, Sorter, Reagents, Consumables, Software), Technology, Application (Research, Clinical - Cancer...
Ginkgo unveils its stock ticker, a biotech venture fund raises $515m, and a unicorn is born By Anissa Gardizy Globe Staff,Updated May 14, 2021, 2 hours ago Email to a Friend Jason Kelly, cofounder and chief executive of Ginkgo Bioworks.Scott Eisen/Bloomberg Hereâs a roundup of five local life-science deals and fundraising events that people are talking about this week. Ginkgo Bioworks After announcing a $17.5 billion merger with a SPAC (blank check company) earlier this week, Ginkgo Bioworks on Friday (finally) unveiled its stock ticker as it plans to go public: âDNA.â The biot...
SPAC Email Thank You Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com Start Investing
Walthamâs PerkinElmer buys Lawrence firm for $260m Nexcelom Bioscienceâs products are used to develop cell and gene therapies and immuno-oncology medicines. By Jonathan Saltzman Globe Staff,Updated May 13, 2021, 5:22 p.m. Email to a Friend A PerkinElmer facility in Valencia, Calif.Marcio Jose Sanchez/Associated Press PerkinElmer, the Waltham-based diagnostics maker, has signed a deal to buy a Lawrence-based firm that makes automated cell-counting instruments for $260 million in cash. The acquisition of Nexcelom Bioscience is expected to close by June 30. Nexcelom products are u...
Search jobs 15-Mar-2021 Image-Based Cytometer Market 2017–2027 Global Analysis, Size, Share, Incredible Growth, Detailed Industry Analysis and Business Prospects | FMI VALLEY COTTAGE, N.Y. – Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the...